News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,665 Results
Type
Article (87421)
Company Profile (759)
Press Release (772462)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233052)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91246)
Employer Resources (203)
FDA (18279)
Job Trends (17399)
News (397380)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (233)
Approvals (18295)
Artificial intelligence (486)
Autoimmune disease (72)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (484)
Bladder cancer (125)
Brain cancer (52)
Breast cancer (482)
Cancer (3861)
Cardiovascular disease (338)
Career advice (3556)
Career pathing (38)
CAR-T (245)
CDC (57)
Cell therapy (681)
Cervical cancer (32)
Clinical research (75380)
Collaboration (1375)
Company closure (4)
Compensation (934)
Complete response letters (59)
COVID-19 (2954)
CRISPR (81)
C-suite (585)
Cystic fibrosis (134)
Data (4348)
Decentralized trials (2)
Denatured (61)
Depression (110)
Diabetes (451)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98789)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132910)
Executive appointments (987)
FDA (20718)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1249)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1017)
Government (5384)
Grass and pollen (7)
Guidances (339)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (53)
Infectious disease (3189)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (95)
Intellectual property (187)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (551)
Lymphoma (264)
Machine learning (29)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14868)
Medtech (14891)
Mergers & acquisitions (22740)
Metabolic disorders (1148)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2710)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (128)
Pain (164)
Pancreatic cancer (168)
Parkinson's disease (242)
Partnered (30)
Patents (415)
Patient recruitment (308)
Peanut (57)
People (66248)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23248)
Phase II (32723)
Phase III (24629)
Pipeline (2698)
Policy (295)
Postmarket research (3554)
Preclinical (10494)
Press Release (72)
Prostate cancer (196)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (666)
Real estate (7421)
Recruiting (78)
Regulatory (27981)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1039)
Venture capital (66)
Weight loss (394)
Women's health (58)
Worklife (21)
Date
Today (107)
Last 7 days (552)
Last 30 days (2511)
Last 365 days (33468)
2025 (26201)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50944)
Australia (8955)
California (9393)
Canada (2849)
China (888)
Colorado (400)
Connecticut (420)
Delaware (262)
Europe (117066)
Florida (1386)
Georgia (315)
Hawaii (3)
Idaho (67)
Illinois (809)
India (51)
Indiana (459)
Iowa (19)
Japan (314)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1274)
Massachusetts (7082)
Michigan (313)
Minnesota (560)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2605)
New Mexico (32)
New York (2561)
North Carolina (1409)
North Dakota (10)
Northern California (4232)
Ohio (295)
Oklahoma (22)
Oregon (50)
Pennsylvania (1960)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3595)
Tennessee (149)
Texas (1475)
United States (34787)
Utah (282)
Virginia (248)
Washington D.C. (83)
Washington State (813)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,665 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, or any other GLP-1 drugmaker.
October 17, 2025
·
3 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Hands Out First Commissioner’s Priority Vouchers to Regeneron, Sanofi, Disc, Others
The Commissioner’s National Priority Voucher awards companies that align with specific national priorities—such as boosting domestic manufacturing and lowering drug prices—with faster reviews and more frequent interactions with the FDA.
October 17, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
EMD Serono will offer its fertility treatments on TrumpRx at a steep discount, and Roche’s direct-to-consumer offering will cover its flu pill Xofluza.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
October 17, 2025
·
4 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
October 17, 2025
·
4 min read
Press Releases
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
October 17, 2025
·
5 min read
Press Releases
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
October 17, 2025
·
18 min read
Press Releases
AB Science announces the successful completion of a EUR 2.8 million private placement
October 17, 2025
·
11 min read
1 of 86,067
Next
